BOLD
Boundless Bio, Inc.
2.80$
+0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Boundless Bio, Inc. (BOLD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -47 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -49 | -85 | -108 | -23 | -40 | -47 | -61 | -47 | |
| 1.6 | 3.7 | 7.5 | 0.7 | 0.9 | 1.0 | 1.1 | 1.3 | |
| 2.0 | 6.9 | 16 | 1.2 | 2.3 | 3.3 | 7.5 | 6.1 | |
| 95 | 23 | 277 | -0.8 | 0.9 | -0.8 | -1.7 | 3.5 | |
| 17 | 7.6 | 12 | 2.0 | 1.1 | 0.6 | 2.5 | 0.5 | |
| -62 | -33 | -185 | -59 | 16 | -38 | -26 | 38 | |
| -36 | -39 | -144 | – | – | – | 0.1 | 0.1 | |
| 75 | 121 | 398 | 106 | 0.1 | 98 | 90 | 0.1 | |
| -36 | 2.6 | 105 | 23 | -23 | 13 | 2.9 | -8.7 | |
| -66 | -92 | -120 | -25 | -41 | -47 | -63 | -47 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.